Gossamer sells rights to drug it hopes can rival a new Merck therapy
BioPharma
Source: biopharmadive.com
Stay updated with breaking news from Acceleron Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Approval of Reblozyl is based on head-to-head, pivotal Phase 3 COMMANDS study, in which Reblozyl nearly doubled the percentage of patients achieving transfusion independence and hemoglobin increase,...
Merck has tapped Betty Larson as EVP, chief human resources officer. Larson brings 20 years of healthcare experience to the role.
Merck bought the company developing the drug for $11.5 billion in 2021
The Food and Drug Administration on Tuesday approved a drug from Merck designed to treat a progressive and life-threatening lung condition in a win for both the...